Consentement d'utilisation des Cookies

J'accepte Notre site sauvegarde des traceurs textes (cookies) sur votre appareil afin de vous garantir de meilleurs contenus et à des fins de collectes statistiques.Vous pouvez désactiver l'usage des cookies en changeant les paramètres de votre navigateur. En poursuivant votre navigation sur notre site sans changer vos paramètres de navigateur vous nous accordez la permission de conserver des informations sur votre appareil.

13412-64-1 - Dicloxacillin sodium salt - J61581 - Alfa Aesar

J61581 Dicloxacillin sodium salt

Numéro CAS
13412-64-1
Synonymes

Dimensions Prix ($) Quantité Disponibilité
1g 55,60
5g 178,00
Ajouter au panier Ajouter au devis en vrac Afficher l'article

Dicloxacillin sodium salt

MDL
MFCD00056865

Propriétés chimiques

Formule
C19H16Cl2N3NaO5S
Poids formulaire
492.33
Forme
Powder
Point de fusion
222-225°
Solubilité
Soluble in water

Applications

Dicloxacillin sodium salt is used in the treatment of staphylococci resistant to penicillin G. Dicloxacillin binds to specific penicillin-binding proteins in the bacterial cell wall and therefore inhibits the last stage of bacterial cell wall synthesis. Cell lysis, mediated by bacterial cell wall autolytic enzymes, is the result. Dicloxacillin may interfere with autolysin inhibitors.

Notes

Keep container tightly closed. Store in cool, dry conditions in well sealed containers.

Références bibliographiques

Lambert K Sorensen.; Birthe M Rasmussen.; Joe O Boison.; Lily Keng. Simultaneous determination of six penicillins in cows' raw milk by a multiresidue high-performance liquid chromatographic method. Journal of Chromatography B: Biomedical Sciences and Applications. 1997, 694, (2), 383-391.

Lambert K. Sorensen.; Lena K. Snor.; Tina Elkaer.; Helga Hansen. Simultaneous determination of seven penicillins in muscle, liver and kidney tissues from cattle and pigs by a multiresidue high-performance liquid chromatographic method. Journal of Chromatography B: Biomedical Sciences and Applications. 1999, 734, (2), 307-318.

Mentions de danger et de prudence du SGH

Mentions de danger (UE): H334-H315-H319-H317-H335-H303

May cause allergy or asthma symptoms or breathing difficulties if inhaled. Causes skin irritation. Causes serious eye irritation. May cause an allergic skin reaction. May cause respiratory irritation. May be harmful if swallowed.

Mentions de prudence: P285-P261-P280-P305+P351+P338-P304+P340-P342+P311-P362-P312-P405-P501a

In case of inadequate ventilation wear respiratory protection. Avoid breathing dust/fume/gas/mist/vapours/spray. Wear protective gloves/protective clothing/eye protection/face protection. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician. Take off contaminated clothing and wash before reuse. Call a POISON CENTER or doctor/physician if you feel unwell. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.

Autres références

Merck
14,3084
Code tarifaire harmonisé
2941.10
TSCA
No
RTECS
XH8925000

Recommandé

  • A10588

    Tetra-n-butylammonium fluoride, 1M soln. in THF
  • 10993

    Cesium chloride, 99.999% (metals basis)
  • J61835

    Bafilomycin A1

Consulté récemment

Produits chimiques

Sciences de la vie

Métaux et matériaux

Catalyseurs

Analytique et matériel de laboratoire